Moderna Inc. posted better-than-expected profits for the last three months of 2021 as the company’s vaccine for Covid-19 continued to power its year-over-year growth.
In the latest quarter, Moderna’s revenue reached $7.21 billion, with nearly all of that coming from vaccine sales. The Cambridge, Mass., company said it distributed a total of 807 million shots last year.
